Skip to main content
Figure 3 | BMC Immunology

Figure 3

From: Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation

Figure 3

Computer-aided homology analysis of LaDR5. A: Homology modeling of LaDR5 Fv, designating VH (pink) and VL fragments (blue). Then CDR domains of heavy and light chains were marked with green (H_CDR1-2), yellow (L_CDR1-2), red (H_CDR3) and white (L_CDR3), respectively; B: theoretical structure of LaDR5 (red)-DR5 (pink) complex. The green-line area was the intact suface of the two; C: The intact suface between DR5-LaDR5, indicating the key residues of DR5 containing Ser35, Glu36, Phe59, Arg62, Arg65, Asp67, Ser68, Ser96, Glu98, Arg101, Lys102, Arg104 and Thr105.

Back to article page